We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
155 hedge funds and large institutions have $1.25B invested in Esperion Therapeutics in 2018 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
9% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 47
4% more capital invested
Capital invested by funds: $1.21B → $1.25B (+$44.2M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less funds holding
Funds holding: 156 → 155 (-1)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
9.71% less ownership
Funds ownership: 115.22% → 105.51% (-9.7%)
77% less call options, than puts
Call options by funds: $34.7M | Put options by funds: $151M
Holders
155
Holders Change
-1
Holders Change %
-0.64%
% of All Funds
3.54%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
24
Increased
51
Reduced
47
Closed
25
Calls
$34.7M
Puts
$151M
Net Calls
-$116M
Net Calls Change
-$36.5M
Top Buyers
| 1 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$8.03M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.57M |
| 3 |
Man Group
London,
United Kingdom
|
+$5.53M |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$4.59M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.59M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$22.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$20.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.8M |
| 4 |
State Street
Boston,
Massachusetts
|
-$15.1M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$13.2M |
